LLY compared with OLMA: revenue, margins and what each company keeps, and the suppliers and customers both name

LLYELI Lilly & Co

Mkt capRevenueRevenue

OLMAOlema Pharmaceuticals, Inc.

Mkt capRevenueRevenue

Compare

LLYELI Lilly & Co

OLMAOlema Pharmaceuticals, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

LLY

3 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±5.1%▲+6.63%×1.29

Q2 FY26±6.2%▲+4.86%×0.79

Q1 FY26±5.3%▲+9.80%×1.85

Feb 4 '26±6.1%▲+10.33%×1.69

OLMA

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±30.4%▼−12.65%×0.42

May 12 '26±32.7%▼−5.99%×0.18

= impliedLLY realized, solidOLMA realized, hatchedOne scale, both sides: full bar = 33%× = |realized| ÷ impliedSource: market data

Q1 FY26

±31.6%

▲+12.85%

×0.41

Jan 13 '26±6.4%▼−3.13%×0.48

LLYELI Lilly & Co

1,360.90▼−0.28%· post 1,358.90

Mkt cap$1.2TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

OLMAOlema Pharmaceuticals, Inc.

7.32▲+8.28%· post 7.32

ClosedNov 6 '26

Mkt cap$641.4MRevenue—Revenue—

Compare

ClosedNov 6 '26

LLYELI Lilly & Co

OLMAOlema Pharmaceuticals, Inc.

1,360.90▼−0.28%post 1,358.90

Price

7.32▲+8.28%post 7.32

$1.2T

Mkt cap

$641.4M

Q3 FY26$24.4B

Revenue

—

FY25$65.2B

Revenue

—

LLY1,360.90▼−0.28%vsOLMA7.32▲+8.28%ClosedNov 6 '26